Close Menu
Home » MDxHealth's Product Sales Jump but Lower Royalty Revenue Hits Top-Line Results

MDxHealth's Product Sales Jump but Lower Royalty Revenue Hits Top-Line Results

Oct 23, 2018
|
staff reporter

NEW YORK (GenomeWeb) – MDxHealth today reported today that its total revenues for the first nine months of 2018 dropped 21 percent, as gains in product and service revenue was offset by lower royalty and patent income.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Walking Around

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

For Better Identification

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

There, In the Water

The New York Times reports on how environmental DNA sampling could monitor endangered species.

Cell Studies Look at Endometrial Cancer 'Omics, Antibiotic Discovery Deep Learning, Lymphoma

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health Q4 Revenues Up 91 Percent

  2. Co-Diagnostics SARS-CoV-2 Assay Garners CE Mark

  3. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

  4. BioMérieux Reports 11 Percent Revenue Growth in Q4

  5. New T2 Biosystems CEO Plans to Shrink Costs, Sharpen Sales Strategy

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.